These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26990224)

  • 1. Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays.
    Chen L; Wang J; Mouser G; Li YC; Marcovici G
    Phytother Res; 2016 Jun; 30(6):1016-20. PubMed ID: 26990224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation.
    Cecchin E; De Mattia E; Mazzon G; Cauci S; Trombetta C; Toffoli G
    Int J Biol Markers; 2014 Dec; 29(4):e310-6. PubMed ID: 24855036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel drug CS-891 inhibits 5alpha-reductase activity in freshly isolated dermal papilla of human hair follicles.
    Niiyama S; Kojima K; Hamada T; Happle R; Hoffmann R
    Eur J Dermatol; 2000 Dec; 10(8):593-5. PubMed ID: 11125319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
    Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
    Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgenetic Alopecia in Gender Minority Patients.
    Marks DH; Senna MM
    Dermatol Clin; 2020 Apr; 38(2):239-247. PubMed ID: 32115134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
    Prager N; Bickett K; French N; Marcovici G
    J Altern Complement Med; 2002 Apr; 8(2):143-52. PubMed ID: 12006122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
    Chen W; Zouboulis CC; Orfanos CE
    Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of finasteride polymer microspheres for systemic application in androgenic alopecia.
    Kim JH; Na J; Bak DH; Lee BC; Lee E; Choi MJ; Ryu CH; Lee S; Mun SK; Park BC; Kim BJ; Lee HS
    Int J Mol Med; 2019 Jun; 43(6):2409-2419. PubMed ID: 30942390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
    Shapiro J; Kaufman KD
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Brief: Self-Reports of a Constellation of Persistent Antiandrogenic, Estrogenic, Physical, and Psychological Effects of Finasteride Usage Among Men.
    Walf AA; Kaurejo S; Frye CA
    Am J Mens Health; 2018 Jul; 12(4):900-906. PubMed ID: 29318957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?
    Traish AM; Melcangi RC; Bortolato M; Garcia-Segura LM; Zitzmann M
    Rev Endocr Metab Disord; 2015 Sep; 16(3):177-98. PubMed ID: 26296373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
    Federman DG
    Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
    [No Abstract]   [Full Text] [Related]  

  • 20. The feasibility of quantitative analysis of androgen metabolism by use of single dermal papillae from human hair follicles.
    Niiyama S; Happle R; Hoffmann R
    Exp Dermatol; 2001 Apr; 10(2):124-7. PubMed ID: 11260251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.